Nuveen’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.27K Buy
+689
New +$2.29K ﹤0.01% 4828
2022
Q1
– Sell
-418,934
Closed -$13.7M – 3398
2021
Q4
$13.7M Buy
418,934
+14,384
+4% +$579K ﹤0.01% 1493
2021
Q3
$16.6M Sell
404,550
-1,243,153
-75% -$45.1M 0.01% 1403
2021
Q2
$59.3M Buy
1,647,703
+637,566
+63% +$23.5M 0.02% 650
2021
Q1
$39.4M Buy
1,010,137
+144,988
+17% +$6.52M 0.01% 863
2020
Q4
$34.9M Buy
865,149
+167,530
+24% +$7.7M 0.01% 897
2020
Q3
$38.8M Buy
+697,619
New +$36.9M 0.01% 680

Other funds holding GDRX

Nuveen's GDRX Position: Q3 2026 in Review

Nuveen opened a new position in GoodRx Holdings (GDRX) in Q3 2026: 689 shares worth $2.27K. The stake represents ﹤0.01% of the portfolio and ranks #4828 among its holdings. This is a return to the name: Nuveen previously reported a position in GDRX as recently as Q4 2021.

Nuveen first reported a position in GDRX in Q3 2020 and has held it in 7 quarters since. The position peaked at $59.3M in Q2 2021. 75 funds tracked by Wall St. Rank hold GDRX as of Q3 2026.

  • Nuveen held 689 shares of GoodRx Holdings worth $2.27K as of Q3 2026.
  • GoodRx Holdings was a new Nuveen position in Q3 2026.
  • GoodRx Holdings made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4828 holding.
  • Nuveen first reported a position in GoodRx Holdings in Q3 2020 and has held it in 7 quarters since.
  • Nuveen's GoodRx Holdings position peaked at $59.3M in Q2 2021.
  • 75 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.